Thoracic Radiotherapy for Limited Stage Small Cell Lung Carcinoma

被引:14
作者
不详
机构
关键词
LEUKEMIA GROUP-B; PHASE-III TRIAL; COMBINED-MODALITY TREATMENT; RADIATION-THERAPY; CONCURRENT CHEMOTHERAPY; CHEST RADIOTHERAPY; PROGNOSTIC-FACTORS; LOCAL-CONTROL; CANCER; IRRADIATION;
D O I
10.1016/j.currproblcancer.2012.03.001
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
[No abstract available]
引用
收藏
页码:88 / 105
页数:18
相关论文
共 59 条
[1]   Impact of Induction Chemotherapy on Estimated Risk of Radiation Pneumonitis in Small Cell Lung Cancer [J].
Amin, Neha P. ;
Miften, Moyed ;
Kavanagh, Brian ;
Raben, David ;
Camidge, D. Ross ;
Thornton, Dale ;
Rochford, Nicole ;
Gaspar, Laurie E. .
JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (09) :1553-1562
[2]  
Argiris A, 2001, CANCER J, V7, P437
[3]   ALTERNATING RADIOTHERAPY AND CHEMOTHERAPY IN LIMITED SMALL-CELL LUNG-CANCER - THE IGR PROTOCOLS [J].
ARRIAGADA, R ;
LECHEVALIER, T ;
RUFFIE, P ;
CHOMY, P ;
DECREMOUX, H .
LUNG CANCER, 1994, 10 :S289-S298
[4]   Concurrent chemotherapy (carboplatin, paclitaxel, etoposide) and involved-field radiotherapy in limited stage small cell lung cancer: a Dutch multicenter phase II study [J].
Baas, P ;
Belderbos, JSA ;
Senan, S ;
Kwa, HB ;
van Bochove, A ;
van Tinteren, H ;
Burgers, JA ;
van Meerbeeck, J .
BRITISH JOURNAL OF CANCER, 2006, 94 (05) :625-630
[5]   70 GY thoracic radiotherapy is feasible concurrent with chemotherapy for limited-stage small-cell lung cancer: Analysis of cancer and leukemia group B study 39808 [J].
Bogart, JA ;
Herndon, JE ;
Lyss, AP ;
Watson, D ;
Miller, AA ;
Lee, ME ;
Turrisi, AT ;
Green, MR .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2004, 59 (02) :460-468
[6]  
Bradley JD, 2011, INT J RAD ONCOL BI S, V81, pLB4
[7]  
CARNEY DN, 1983, CANCER RES, V43, P2806
[8]   IMPORTANCE OF RADIATION-DOSE IN ACHIEVING IMPROVED LOCO-REGIONAL TUMOR-CONTROL IN LIMITED STAGE SMALL-CELL LUNG-CARCINOMA - AN UPDATE [J].
CHOI, NC ;
CAREY, RW .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 1989, 17 (02) :307-310
[9]   Phase I study to determine the maximum-tolerated dose of radiation in standard daily and hyperfractionated-accelerated twice-daily radiation schedules with concurrent chemotherapy for limited-stage small-cell lung cancer [J].
Choi, NC ;
Herndon, JE ;
Rosenman, J ;
Carey, RW ;
Chung, CT ;
Bernard, S ;
Leone, L ;
Seagren, S ;
Green, M .
JOURNAL OF CLINICAL ONCOLOGY, 1998, 16 (11) :3528-3536
[10]  
ClinicalTrials.gov, CISPL ET 2 DIFF SCHE